Microbot Medical Inc. (NASDAQ:MBOT) Director Yoseph Bornstein sold 20,000 shares of the business’s stock in a transaction on Tuesday, September 12th. The stock was sold at an average price of $1.12, for a total transaction of $22,400.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Yoseph Bornstein also recently made the following trade(s):

  • On Wednesday, September 6th, Yoseph Bornstein sold 45,610 shares of Microbot Medical stock. The stock was sold at an average price of $1.01, for a total transaction of $46,066.10.

Microbot Medical Inc. (NASDAQ MBOT) traded down 1.90% during trading on Thursday, hitting $1.03. 489,760 shares of the company’s stock traded hands. Microbot Medical Inc. has a 52-week low of $1.00 and a 52-week high of $15.66. The company’s 50 day moving average price is $1.12 and its 200 day moving average price is $3.22. The company’s market cap is $45.36 million.

Microbot Medical (NASDAQ:MBOT) last released its earnings results on Monday, August 14th. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.48) by $0.44. Analysts expect that Microbot Medical Inc. will post ($25.02) earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Microbot Medical Inc. (MBOT) Director Yoseph Bornstein Sells 20,000 Shares” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/14/microbot-medical-inc-mbot-director-yoseph-bornstein-sells-20000-shares.html.

Separately, ValuEngine upgraded shares of Microbot Medical from a “strong sell” rating to a “sell” rating in a report on Friday, June 2nd.

A hedge fund recently raised its stake in Microbot Medical stock. Bank of Montreal Can lifted its holdings in shares of Microbot Medical Inc. (NASDAQ:MBOT) by 90,909.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,022 shares of the biotechnology company’s stock after purchasing an additional 20,000 shares during the period. Bank of Montreal Can owned about 0.07% of Microbot Medical worth $116,000 at the end of the most recent reporting period. Institutional investors own 4.72% of the company’s stock.

About Microbot Medical

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Receive News & Ratings for Microbot Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.